<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11484">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01764906</url>
  </required_header>
  <id_info>
    <org_study_id>BA06-CP01</org_study_id>
    <nct_id>NCT01764906</nct_id>
  </id_info>
  <brief_title>the Clinical Study of Novosis in Posterolateral Fusion</brief_title>
  <official_title>The Clinical Study to Evaluate the Efficacy and Safety of Novosis in Posterolateral Fusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioAlpha Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioAlpha Inc.</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacay and safety of Novosis in
      posterolateral fusion
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fusion grade by CT assessments after surgery</measure>
    <time_frame>24 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fusion grade by Radiographic assessments after surgery</measure>
    <time_frame>24 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Posterolateral Fusion</condition>
  <arm_group>
    <arm_group_label>Novosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bongros/BMP-2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iliac crest bone graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Iliac crest bone graft</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Novosis</intervention_name>
    <arm_group_label>Novosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Iliac crest bone graft</intervention_name>
    <arm_group_label>Iliac crest bone graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18~80 aged patients needed single-level posterolateral fusion at L1~S1

          -  A subject who provided written informed consent to participate in this study

        Exclusion Criteria:

          -  Patitents with BMD T-score &lt; -3.0

          -  Women who are pregnant or plan to be pregnant within study period
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jun-Hyuk Seo</last_name>
    <email>seoscy@daewoong.co.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>JaeHyup Lee</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 8, 2013</lastchanged_date>
  <firstreceived_date>January 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
